Results 91 to 100 of about 1,762,642 (311)

Accuracy of tests for predicting spontaneous preterm birth: Systematic reviews of diagnostic research [PDF]

, 2010
Spontaneous preterm birth complicates about 3% of pregnancies before 34 weeks’ gestation and 7 – 12% before 37 weeks’ gestation. It is an important issue to public health worldwide.
Honest, H
core   +5 more sources

Predicting preeclampsia from a history of preterm birth.

PLoS ONE, 2017
ObjectiveTo assess whether women with a history of preterm birth, independent on the presence of prelabour rupture of the membranes (PROM) and growth deviation of the newborn, are more likely to develop preeclampsia with preterm or preterm birth in a ...
Svein Rasmussen, Cathrine Ebbing, Lorentz M Irgens   +2 more
doaj   +1 more source

The association between parity and spontaneous preterm birth: a population based study

BMC Pregnancy and Childbirth, 2020
Background Preterm birth is the leading cause of perinatal mortality and neonatal morbidity worldwide. Many factors have been associated with preterm birth, including parity. The aim of the present study was to investigate associations between parity and
Bouchra Koullali, Maud D. van Zijl, Brenda M. Kazemier, Martijn A. Oudijk, Ben W. J. Mol, Eva Pajkrt, Anita C. J. Ravelli   +6 more
doaj   +1 more source

The role of progesterone in prevention of preterm birth

, 2009
Preterm birth continues to provide an enormous challenge in the delivery of perinatal health care, and is associated with considerable short and long-term health consequences for surviving infants.
Caroline A Crowther, Crowther, C., null Crowther, Jodie Dodd, Jodie M Dodd, Dodd, J.   +5 more
core   +1 more source

Effect of developmental changes on pharmacokinetics of drugs used in the treatment of infant acute lymphoblastic leukaemia—A comprehensive review

British Journal of Clinical Pharmacology, EarlyView.
While the event‐free survival (EFS) of children treated for acute lymphoblastic leukaemia (ALL) has improved greatly in the last decades, the EFS for patients diagnosed with ALL before the age of one is still under 50%. This outcome further decreases when infants have a rearrangement in the gene encoding histone‐lysine N‐methyltransferase 2A (KMT2A ...
Tirsa de Kluis, Leiah J. Brigitha, Lidwien M. Hanff, Alwin D. R. Huitema, Inge M. van der Sluis, Meta H. M. Diekstra   +5 more
wiley   +1 more source

Pentoxifylline dose finding trial in preterm neonates with suspected late onset sepsis (PTX‐trial)

British Journal of Clinical Pharmacology, EarlyView.
Aim The aim of this study (PTX‐trial) is to determine the optimal dose of pentoxifylline (PTX) in preterm neonates (gestational age < 30 weeks) with (suspected) late onset sepsis (LONS). Methods The PTX‐trial is a prospective multicentre open‐label sequential dose‐optimization study with an adapted continual reassessment method.
Serife Kurul, H. Rob Taal, Jan Mazela, Ryszard Lauterbach, Irwin K. M. Reiss, Karel Allegaert, Robert B. Flint, Sinno H. P. Simons   +7 more
wiley   +1 more source

Revisiting the association between maternal and offspring preterm birth using a sibling design

BMC Pregnancy and Childbirth, 2019
Background Previous studies have reported an intergenerational association between maternal and offspring preterm birth (PTB) but the nature of the association remains unclear.
Marcelo L. Urquia, Elizabeth Wall-Wieler, Chelsea A. Ruth, Xiaoqing Liu, Leslie L. Roos   +4 more
doaj   +1 more source

Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin‐resistant tuberculosis

British Journal of Clinical Pharmacology, EarlyView.
Levofloxacin is a widely used antibiotic included in rifampicin‐resistant tuberculosis (RR‐TB) treatment. Data describing levofloxacin concentrations in breastmilk and infant exposure are limited. We analysed data from two South African studies of breastfeeding women receiving levofloxacin (750–1000 mg daily) for RR‐TB.
Sharon Sawe, Lufina Tsirizani, Buyisile Mkhize, Lubbe Wiesner, Gary Maartens, Francesca Conradie, Richard Court, Marian Loveday, Catriona Waitt, Paolo Denti   +9 more
wiley   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. [PDF]

, 2014
OBJECTIVE: To examine the timing and duration of RSV bronchiolitis hospital admission among term and preterm infants in England and to identify risk factors for bronchiolitis admission.
Paul Aylin (355512), Aylin, P, Sonia Saxena, Murray, J, Bottle, A, Bottle Alex, Joanna Murray, Paul Aylin, Saxena, S, Sonia Saxena (258806), Medicines for Neonates Investigator Group, Alex Bottle, Azeem Majeed (69210), Aylin Paul, Modi, N, Alex Bottle (258808), Sharland Mike, Majeed, A, Majeed Azeem, Mike Sharland (258810), Saxena Sonia, Neena Modi, Modi Neena, Mike Sharland, Joanna Murray (527948), Neena Modi (527789), Sharland, M, Azeem Majeed, Murray Joanna, Majeed, Azeem, Petrou, Stavros, Young, Annie M., Costeloe, Kate, Bottle, Alex, Modi, N., Modi, Neena, Brocklehurst, Peter, Saxena, Sonia, Abbott, J., Draper, E. S., Ashby, Deborah, Aylin, Paul, Kemp, J., Sharland, Mike, Murray, Joanna   +44 more
core   +1 more source